comparemela.com

Latest Breaking News On - Vasc dis - Page 1 : comparemela.com

Clinical Overview: Sotagliflozin (Inpefa) for Heart Failure

Sotagliflozin (Inpefa) is an orally administered dual SGLT1/2 inhibitor that reduces the risk of death due to heart failure.

Lexicon pharmaceuticals incAmerican college of cardiologyAfrica studioSotagliflozin approved for broadAmerican collegeVasc disRecent worsening heartNew drugChronic kidneyLexicon pharmaceuticals

Best Meal Replacement Shakes that Really Work for Weight Loss

Looking for the best meal replacement shakes for weight loss? Here are some of the best meal replacement shakes on the market.

United kingdomNational health serviceGroup swimmersBiomed research internationalBest meal replacement shakesReally workKnockout completeMeal replacement shakeNutritional shakeLabs meal replacement powdersFat burning meal replacementPlant proteinWhole body mealLean meal shakeNone organicVegan meal replacement

Help Patients Improve Glycemic Control for T2D

Keeping blood glucose levels within a target range delays, prevents serious health complications associated with type 2 diabetes.

Colorado springsUnited statesKathleen kennyNational institute of diabetesGlobal partnership for effective diabetes managementAmerican diabetes associationAmerican diabetesPrediabetic hbaHealthline mediaGlobal partnershipEffective diabetesVasc disAccessed marchUpdated decemberUpdated november

vimarsana © 2020. All Rights Reserved.